Eli Lilly And reported $1.72B in Cost of Sales for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbvie ABBV:US $ 4684M 366M
Amgen AMGN:US $ 1597M 36M
AstraZeneca AZN:LN 1515M 125M
Astrazeneca AZN:US 1.52B 125M
Baxter International BAX:US $ 1962M 190M
Biogen BIIB:US $ 490.6M 41.5M
Bristol Myers Squibb BMY:US $ 2302M 197M
Catalent CTLT:US $ 612.6M 15.8M
Coherus Biosciences CHRS:US $ 11.67M 2.67M
Drreddys Laboratories RDY:US $ 22558M 3138M
Eli Lilly And LLY:US $ 1719.8M 393.4M
Endo International Ordinary Shares ENDP:US $ 369.54M 21.46M
Gilead Sciences GILD:US $ 1398M 257M
GlaxoSmithKline GSK:LN 2962M 244M
Glaxosmithkline GSK:US $ 2962M 244M
Horizon Pharma HZNP:US $ 162.29M 10.81M
Intercept Pharmaceuticals ICPT:US $ 0.77M 1.06M
JAZZ PHA JAZZ:US $ 50.16M 8.06M
Lannett LCI:US $ 133.15M 32.37M
Medtronic MDT:US $ 2585M 88M
Merk MRK:US $ 5489M 2046M
Neurocrine Biosciences NBIX:US $ 2.9M 0.2M
Novartis NOVN:VX SF 3940M 372M
Novartis NVS:US $ 3940M 372M
Pfizer PFE:US $ 2887M 390M
Phibro Animal Health PAHC:US $ 137.88M 6.81M
Prestige Brands PBH:US $ 99.9M 0.14M
Regeneron Pharmaceuticals REGN:US $ 353.1M 79.1M
Revance Therapeutics RVNC:US $ 3.66M 2.58M
Teva Pharmaceutical Industries TEVA:US $ 2372M 244M
United Therapeutics UTHR:US $ 34.8M 10.8M
Zoetis ZTS:US $ 598M 55M